Evidence map›Paper›PMID 33622731›Full record

ArticlemBio2021

All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections.

Martin Hoenigl, Stuart M Levitz, Audrey N Schuetz, Sean X Zhang, Oliver A Cornely

Open access · goldAbstract readComment
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. First clinical isolation ofOxford medical case reports · 2026
    Article
  2. Journal of fungi (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Martin HoeniglSection of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria hoeniglmartin@gmail.com.ORCID 0000-0002-1653-2824
Stuart M LevitzDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Audrey N SchuetzDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-5837-270X
Sean X ZhangMicrobiology Laboratory, Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0003-1166-2563
Oliver A CornelyUniversity of Cologne, Faculty of Medicine, Cologne, Germany.ORCID 0000-0001-9599-3137
Johns Hopkins University · USMayo Clinic · USMedical University of Graz · ATUniversity of Cologne · DEUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive mold infections caused by molds other than

Indexed as

AscomycotaFusariumScedosporiumAnimalsDrug Resistance, FungalHumansMycologyUnited StatesbasidiomycetesdiagnosisFusariumLomentosporamoldsPaecilomycesPenicilliumPhaeohyphomycosisRasamsoniaScedosporiumScopulariopsistreatment

Identifiers

PMID33622731
PMCPMC8545092
OpenAlexW3132307897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.